Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment Survival

When Gwen Watson was diagnosed with glioblastoma (GBM), an aggressive brain cancer, she and her husband didn’t hesitate to drive four and a half hours from their home in DeLand, Florida, to Baptist Health’s Miami Cancer Institute so that she could receive state-of-the art multi-disciplinary care and enroll in a clinical trial. “My family did a lot of research on where I could get the best treatment,” Ms. Watson said. “And Miami Cancer Institute was that place.”

Click here to learn more.

Created by

Baptist Health South Florida

Related Presenters

Rupesh Rajesh Kotecha, MD

Rupesh Rajesh Kotecha, MD

Chief of Radiosurgery Radiation Oncology

View full profile